Log in

Relevant bibliographies by topics / Inflammatory bowel diseas / Journal articles

To see the other types of publications on this topic, follow the link: Inflammatory bowel diseas.

Journal articles on the topic 'Inflammatory bowel diseas'

Author: Grafiati

Published: 1 February 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Inflammatory bowel diseas.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

KASKI, M. CARPANI, and H. J. F. HODGSON. "Rolling review: inflammatory bowel diseas." Alimentary Pharmacology & Therapeutics 7, no. 5 (March 31, 2007): 567–79. http://dx.doi.org/10.1111/j.1365-2036.1993.tb00134.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

O’Sullivan, Maria, and Colm O’Morain. "Nutritional therapy in inflammatory bowel diseas." Current Treatment Options in Gastroenterology 7, no. 3 (June 2004): 191–98. http://dx.doi.org/10.1007/s11938-004-0040-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Mancho, Carolina, Ángel Sainz, Mercedes García-Sancho, Alejandra Villaescusa, Miguel A. Tesouro, and Fernando Rodríguez-Franco. "Detection of Perinuclear Antineutrophil Cytoplasmic Antibodies and Antinuclear Antibodies in the Diagnosis of Canine Inflammatory Bowel Diseas." Journal of Veterinary Diagnostic Investigation 22, no. 4 (July 2010): 553–58. http://dx.doi.org/10.1177/104063871002200409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Theocharidou, Eleni, Melachrini Mavroudi, Konstantinos Soufleris, Alexandros Mpoumponaris, Andreas Nakos, Theodora Griva, Nikolaos Grammatikos, Eleni Mavroudi, Geleris Paraschos, and Nicolaos Evgenidis. "T1333 Increased Pulse Wave Velocity in Patients With Inflammatory Bowel Diseas. Preliminary Results of an Ongoing Study." Gastroenterology 138, no. 5 (May 2010): S—539. http://dx.doi.org/10.1016/s0016-5085(10)62486-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Alexander, Richard J., Asit Panja, Evonne Kaplan-Liss, Lloyd Mayer, and Robert F. Raicht. "Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel diseas." Digestive Diseases and Sciences 40, no. 3 (March 1995): 485–94. http://dx.doi.org/10.1007/bf02064355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Eindor, A., L. Meleady, and K. Jacobson. "P147 Progression to biologic treatment in very early onset inflammatory bowel disease patients- a long term follow up retrospective study." Journal of Crohn's and Colitis 15, Supplement_1 (May 1, 2021): S229—S230. http://dx.doi.org/10.1093/ecco-jcc/jjab076.274.

Full text

Abstract:

Abstract Background Very early onset inflammatory bowel disease (VEOIBD) prevalence has been increasing over the last decades. These young patients have been known to have special disease characteristics and disease location. Although it is known that only a low percentage of these patients require biologic treatment after diagnosis, there is only scarce evidence about their long- term outcome and biologic requirements. We aimed to assess the long term outcome of VEOIBD patients and the time of progression to biologic treatment. Methods We retrospectively reviewed IBD patients diagnosed under 6 years of age, between January 2005 and December 2019, from the British Columbia (BC) Pediatric IBD database. Demographic data, disease characteristics and symptoms at diagnosis were documented. The disease location and severity were documented according to the Paris classification. Data collected retrospectively until the last appointment recorded in the electronic medical records included whether the patient received biologic treatment at the time of follow up, the time to intiation of the treatment, the type of biologic treatment and response. Kaplan meier curves were used to asses the number of years to progression to biologic treatment and the parameters influencing it. Results 89 patients under the age of 6 were diagnosed with IBD during the study period. 3 patients failed to meet inclusion criteria and were excluded. Median age at diagnosis was 3.8 (IQR 2.6–5.1). 45.3% of patients had Crohn’s disease (CD) and 62.8% were males. Median time of follow up was 6.39 (IQR 3.71–10.55). 68.1% of the ulcerative colitis (UC) patients had pancolitis and 48.7% of CD patients had ileocolonic disease. 39.5% of patients were started on biologic treatment and 7.1% underwent surgery. Kaplan Meier curves demonstrated that patients diagnosed in the years 2012 -2019 had shorter duration of progression to biologics than those diagnosed 2005–2011 (p=0.0047). In patients with CD those with perianal or stricturing disease progressed faster to biologic treatment (p=0.024,p=0.038, respectively) and in UC patients those with high severity of disease (p=0.017). 63.6% of patients were reported to be on clinical remission on the biologic treatment. Conclusion Although VEOIBD patients have more extensive diseas, they require less biologic treatment than previously reported in older patients. Factors influencing shorter duration of progression to biologics were the severity of disease and behaviour and not disease location. Patients diagnosed more recently had shorter duration to biologic treatment which might reflect physicians perception on using biologic treatment in these young patients rather than disease severity.

APA, Harvard, Vancouver, ISO, and other styles

7

Falcón-Guerrero, Britto Ebert. "Coincidencia entre la periodontitis y la enfermedad inflamatoria del intestino." Kiru 20, no. 1 (March 31, 2023): 28–33. http://dx.doi.org/10.24265/kiru.2023.v20n1.03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

HUSNÍK, R., J. KLIMEŠ, K. TOMANOVÁ, J. SMOLA, R. HALOUZKA, F. TICHÝ, and J. BRÁZDIL. "Lawsonia intracellularis in a dog with inflammatory bowel disease." Veterinární Medicína 48, No. 5 (March 30, 2012): 141–45. http://dx.doi.org/10.17221/5761-vetmed.

Full text

Abstract:

A two-year-old male German short-haired pointer was presented with a 1.5-year history of intermittent small-bowel diarrhoea. Inflammatory bowel disease (chronic lymphocytic-plasmacytic gastritis, enteritis and colitis) was diagnosed on the basis of histological examination of biopsies obtained on repeated endoscopy and by exclusion of other possible causes. Warthin-Starry silver staining of stomach mucosa revealed the presence of gastric spiral organisms. The evidence of L. intracellularis was provided by a positive nested polymerase chain reaction in one biopsy of duodenal mucosa and in one rectal smear. In 5 blood sera collected over a period of 8 months the IgG antibodies to L. intracellularis were found by an indirect fluorescent antibody test. Treatment with oral prednisone led only to a temporary improvement.

APA, Harvard, Vancouver, ISO, and other styles

9

Fernandes, Isabel, and Lúcia Gil. "Qualidade de vida da pessoa com doença inflamatória intestinal." Revista de Enfermagem Referência IV Série, no. 23 (December 23, 2019): 89–98. http://dx.doi.org/10.12707/riv19048.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kumar Kasula Suresh, Bharath. "Emerging Therapies for Inflammatory Bowel Disease: A Systematic Overview." International Journal of Science and Research (IJSR) 13, no. 3 (March 5, 2024): 1449–51. http://dx.doi.org/10.21275/mr24322201434.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Kumar, Puneet, Sunita Devi, Pramod Kumar, Nisha Devi, and Shivali Singla. "A Review on Inflammatory Bowel Disease: Diagnosis and Treatment." International Journal of Science and Research (IJSR) 11, no. 4 (April 5, 2022): 412–14. http://dx.doi.org/10.21275/sr22406110623.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

S, Hajare. "A Demographic Profile of Inflammatory Bowel Disease in Uttar Karnataka." Gastroenterology & Hepatology International Journal 4, no. 2 (July 22, 2019): 1–7. http://dx.doi.org/10.23880/ghij-16000165.

Full text

Abstract:

Inflammatory bowel disease (IBD) results from production of dysregulated gut mucosal immune response to luminal antigens. Scientific literature pertaining to Southern part of Indian is limited, especially with focus on demographic and clinical phenotypes of IBD. Hence, the present study is aimed at evaluating these factors in a geographic area of Uttar Karnataka in two types of IBD- Ulcerative colitis (UC) and Crohn’s disease (CD). Methodology: A retrospective study was done with 91 patients with IBD from 2009 to 2019. Patients were routinely started on treatment with local and systemic 5-aminosalicylic acid derivatives. Different line of therapies was administered to both UC and Crohn’s disease with different drugs or combination of drugs. Results: Of the 91 patients, 85 were having UC and 6 with CD. The mean age of patients with UC and CD was 41.8 years and 52.2 years; male predominance was observed in UC group of patients in contrast to CD group. UC patients were found with Extraintestinal manifestation i.e. Erythema nodosum (0.01%), Type 1 peripheral arthritis (0.01%), Type 2 peripheral arthritis (0.01%). A total of 6 UC patients required surgery for various causes, with the majority being males, including 2 of them who developed cancer. Conclusion: There was a predominance of patients with UC, especially in men. The age, origin and level of education may interfere with early diagnosis. This geographical region survey provides an opportunity for understanding possible etiopathogenetic factors associated with the disease and pattern of treatment.

APA, Harvard, Vancouver, ISO, and other styles

13

Bustelo, Dolores, and Tatiana Fazecas. "A importância da ultrassonografia com Doppler na doença inflamatória intestinal em pediatria." Radiologia Brasileira 56, no. 5 (September 2023): IX—X. http://dx.doi.org/10.1590/0100-3984.2023.56.5e3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Dudanova, Olga Petrovna, Nadezhda Alekseevna Larina, Lidija Valerievna Prokapovich, and Anastasia Andreevna Larina. "Steatohepatitis in patients with inflammatory bowel diseases in Karelia." Journal of Biomedical Technologies, no. 1 (June 2014): 10–17. http://dx.doi.org/10.15393/j6.art.2014.2981.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Garg, Praveen Kumar, Taruna Choudhary, and Bharat Gomtiwall. "To Study of Spectrum of Inflammatory Bowel Disease in Western Rajasthan." Asian Journal of Medical Research 8, no. 2 (June 2019): ME15—ME17. http://dx.doi.org/10.21276/ajmr.2019.8.2.me6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Kastуukevich, L. I., O. N. Romanova, N. D. Kolomiets, K. Y. Marakhovsky, O. V. Krasko, O. N. Nazarenko, and O. L. Savich. "СРАВНИТЕЛЬНАЯ ХАРАКТЕРИСТИКА РАЗНЫХ ТИПОВ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ КИШЕЧНИКА У ДЕТЕЙ." Hepatology and Gastroenterology 7, no. 2 (December 2023): 127–34. http://dx.doi.org/10.25298/2616-5546-2023-7-2-127-134.

Full text

Abstract:

Background. Inflammatory bowel disease (IBD) is a group of idiopathic, chronic, relapsing inflammatory conditions of the gastrointestinal tract including ulcerative colitis (UC), Crohn's disease (CD), and unspecified colitis (UnC). Objective. To provide a comparative characteristic of clinical and laboratory features of various IBD types in children according to the morphology, and to identify clinical and laboratory markers of unspecified colitis in children. Material and methods. 118 pediatric patients diagnosed with chronic inflammatory bowel disease were observed. Statistical processing of clinical and laboratory data was carried out using the statistical package R, version 4.1. Results. A comprehensive examination revealed 36 patients with Crohn's disease (CD), 54 those with ulcerative colitis (UC), and 28 with UnC. It was found out that in patients diagnosed with unspecified colitis, clinical manifestations were statistically more often observed at an earlier age (28,5 months [8; 50]) in contrast to children with UC (31 months [14; 122]) and CD patients (96 months [34,5;132]) (p=0,004). All patients with IBD had significant changes in stool frequency (from 3 to 9 or more times per day), 45 (83.3%) patients with UC having blood in stool (p <0.001). Pain syndrome was less common in patients diagnosed with UnC – 22 (78,6%) (p=0,048). The two clinical and laboratory symptoms were significantly more often observed in the group of patients with UC: protein-energy malnutrition (PEM) – 24 (44,4%)(p=0.008) and anemia – 39 (72,2%) (p<0.001). Patients diagnosed with UnC had a lower platelet count (292±68) (p=0.005). CD patients had a lower mean relative lymphocyte count (30,8%) (p=0.005). The level of C-reactive protein (CRP) was significantly more often elevated in patients with UC – 30 (55,6%) (p=0,005). Conclusions. Though standard methods used for examining patients with IBD allow us to establish the diagnoses of UC and CD, such examination is not sufficient for children with UnC. It is necessary to include new molecular genetic criteria in the examination protocol for patients with IBD, which will make it possible to offer appropriate treatment at an early stage of the disease.

APA, Harvard, Vancouver, ISO, and other styles

17

K Tyagi, C., Anju Balkrishna Bhandole, and Harish N Kakrani. "Evaluation of Herbal Plants Used in Treatment of Inflammatory Bowel Disease." International Journal of Science and Research (IJSR) 11, no. 12 (December 5, 2022): 950–57. http://dx.doi.org/10.21275/sr221212152611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Banakar, Ranjeeta S., and Rangaswamy R. "Spectrum of Histopathology of Inflammatory Bowel Disease in A Teaching Hospital, Bangalore." Indian Journal of Pathology: Research and Practice 7, no. 2 (2018): 207–11. http://dx.doi.org/10.21088/ijprp.2278.148x.7218.13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Mounika, Gai, Vuppunuthala Ramkamladhar, Ch Praneeth Kumar, and K. Ravinder Reddy. "Unveiling Strongyloidiasis: A Mimicker of Inflammatory Bowel Disease with Unique Clinical Presentation." International Journal of Science and Research (IJSR) 12, no. 9 (September 5, 2023): 646–47. http://dx.doi.org/10.21275/sr23905105335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Beal, Eliza W., Rosara Bass, and Alan E. Harzman. "Two Patients with FulminantClostridium difficileEnteritis Who Had Not Undergone Total Colectomy: A Case Series and Review of the Literature." Case Reports in Surgery 2015 (2015): 1–5. http://dx.doi.org/10.1155/2015/957257.

Full text

Abstract:

Introduction.Clostridium difficileis the most common cause of healthcare associated infectious diarrhea, and its most common clinical manifestation is pseudomembranous colitis. Small bowel enteritis is reported infrequently in the literature and typically occurs only in patients who have undergone ileal pouch anastomosis due to inflammatory bowel disease or total abdominal colectomy for other reasons.Presentation of Cases. We report here two cases in which patients developed small bowelC. difficileenteritis in the absence of these underlying conditions.Discussion. Neither patient had underlying inflammatory bowel disease and both had a significant amount of colon remaining.Conclusion. These two cases demonstrate that small bowelC. difficileenteritis should be included in the differential diagnosis of patients on antibiotic therapy who demonstrate signs and symptoms of worsening abdominal disease during their postoperative course, even if they lack the major predisposing factors of inflammatory bowel disease or history of total colectomy.

APA, Harvard, Vancouver, ISO, and other styles

21

Ahmed Majeed, Hiba. "Detection of Cytomegalovirus in Patients with Inflammatory Bowel Diseases in Iraq." Journal of Communicable Diseases 55, no. 03 (December 7, 2023): 67–74. http://dx.doi.org/10.24321/0019.5138.202341.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Patel, Parth, Richa Sharma, and Yatish x. "Association of Self Medication with Analgesics and Smoking among Inflammatory Bowel Disease Patients." International Journal of Science and Research (IJSR) 11, no. 9 (September 5, 2022): 860–61. http://dx.doi.org/10.21275/mr22916223327.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sewell, Justin L., and Uma Mahadevan. "Of Blemishes and Bowels: Isotretinoin and Inflammatory Bowel Disease." Gastroenterology 138, no. 1 (January 2010): 392–94. http://dx.doi.org/10.1053/j.gastro.2009.11.029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Hyams, J. S. "Inflammatory Bowel Disease." Pediatrics in Review 26, no. 9 (September 1, 2005): 314–20. http://dx.doi.org/10.1542/pir.26-9-314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Glick, S. R., and R. S. Carvalho. "Inflammatory Bowel Disease." Pediatrics in Review 32, no. 1 (December 31, 2010): 14–25. http://dx.doi.org/10.1542/pir.32-1-14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Shapiro, J. M., S. Subedi, and N. S. LeLeiko. "Inflammatory Bowel Disease." Pediatrics in Review 37, no. 8 (August 1, 2016): 337–47. http://dx.doi.org/10.1542/pir.2015-0110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Hyams, J. S. "Inflammatory Bowel Disease." Pediatrics in Review 21, no. 9 (September 1, 2000): 291–95. http://dx.doi.org/10.1542/pir.21-9-291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Moses, Peter L., Brad R. Moore, Nicholas Ferrentino, Steven P. Bensen, and James A. Vecchio. "Inflammatory bowel disease." Postgraduate Medicine 103, no. 5 (May 1998): 77–102. http://dx.doi.org/10.3810/pgm.1998.05.483.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Glick, Sarah R., and Ryan S. Carvalho. "Inflammatory Bowel Disease." Pediatrics In Review 32, no. 1 (January 1, 2011): 14–25. http://dx.doi.org/10.1542/pir.32.1.14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hyams, Jeffrey S. "Inflammatory Bowel Disease." Pediatrics In Review 21, no. 9 (September 1, 2000): 291–95. http://dx.doi.org/10.1542/pir.21.9.291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Hyams, Jeffrey S. "Inflammatory Bowel Disease." Pediatrics In Review 26, no. 9 (September 1, 2005): 314–20. http://dx.doi.org/10.1542/pir.26.9.314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Moll, J. M. H. "Inflammatory Bowel Disease." Clinics in Rheumatic Diseases 11, no. 1 (April 1985): 87–111. http://dx.doi.org/10.1016/s0307-742x(21)00590-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

MAYBERRY, J. F. "Inflammatory Bowel Disease." Gut 49, no. 2 (August 1, 2001): 314.3–314. http://dx.doi.org/10.1136/gut.49.2.314-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Vatn, Morten H., and Arne K. Sandvik. "Inflammatory bowel disease." Scandinavian Journal of Gastroenterology 50, no. 6 (April 8, 2015): 748–62. http://dx.doi.org/10.3109/00365521.2015.1033000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Podolsky, Daniel K. "Inflammatory Bowel Disease." New England Journal of Medicine 347, no. 6 (August 8, 2002): 417–29. http://dx.doi.org/10.1056/nejmra020831.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Abraham, Clara, and Judy H. Cho. "Inflammatory Bowel Disease." New England Journal of Medicine 361, no. 21 (November 19, 2009): 2066–78. http://dx.doi.org/10.1056/nejmra0804647.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Schuman, Bernard M. "Inflammatory bowel disease." Postgraduate Medicine 83, no. 4 (March 1988): 291–94. http://dx.doi.org/10.1080/00325481.1988.11700202.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Floch, Martin H. "Inflammatory Bowel Disease." Journal of Clinical Gastroenterology 45, no. 9 (October 2011): 839. http://dx.doi.org/10.1097/mcg.0b013e31822be119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hanauer, Stephen B., and Daan W. Hommes. "Inflammatory bowel disease." Expert Review of Clinical Immunology 6, no. 4 (July 2010): 499–500. http://dx.doi.org/10.1586/eci.10.52.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

McClenathan, Daniel T. "Inflammatory Bowel Disease." Journal of Pediatric Gastroenterology and Nutrition 10, no. 2 (February 1990): 277. http://dx.doi.org/10.1097/00005176-199002000-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Schölmerich, J. "Inflammatory Bowel Disease." Endoscopy 28, no. 01 (January 1996): 77–82. http://dx.doi.org/10.1055/s-2007-1005421.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Ottenjann, R. "Inflammatory Bowel Disease." Endoscopy 26, no. 01 (January 1994): 64–69. http://dx.doi.org/10.1055/s-2007-1005812.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zakaria, Alan A., and Sami F. Rifat. "Inflammatory Bowel Disease." Current Sports Medicine Reports 7, no. 2 (March 2008): 104–7. http://dx.doi.org/10.1097/01.csmr.0000313398.94816.47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ambrose, N. S. "Inflammatory bowel disease." Current Opinion in Gastroenterology 2, no. 3 (May 1986): 377–78. http://dx.doi.org/10.1097/00001574-198605000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rhodes, J. M. "Inflammatory bowel disease." Current Opinion in Gastroenterology 2, no. 3 (May 1986): 405–9. http://dx.doi.org/10.1097/00001574-198605000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

&NA;. "Inflammatory bowel disease." Current Opinion in Gastroenterology 2, no. 3 (May 1986): 449–56. http://dx.doi.org/10.1097/00001574-198605000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Ambrose, N. S. "Inflammatory bowel disease." Current Opinion in Gastroenterology 3, no. 3 (May 1987): 423. http://dx.doi.org/10.1097/00001574-198705000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Rhodes, J. M. "Inflammatory bowel disease." Current Opinion in Gastroenterology 3, no. 3 (May 1987): 438–43. http://dx.doi.org/10.1097/00001574-198705000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Ambrose, N. S. "Inflammatory bowel disease." Current Opinion in Gastroenterology 3, no. 3 (May 1987): 460–64. http://dx.doi.org/10.1097/00001574-198705000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

&NA;. "Inflammatory bowel disease." Current Opinion in Gastroenterology 3, no. 3 (May 1987): 523–32. http://dx.doi.org/10.1097/00001574-198705000-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!